A Novel Mammalian Lithium-sensitive Enzyme with a Dual Enzymatic Activity, 3'-Phosphoadenosine 5'-Phosphate Phosphatase and Inositol-polyphosphate 1-Phosphatase*

José M. López-Coronado, José M. Bellés, Florian LesageDagger , Ramón Serrano, and Pedro L. Rodríguez§

From the Instituto de Biología Molecular y Celular de Plantas, Universidad Politécnica de Valencia-Consejo Superior de Investigaciones Científicas, Camino de Vera, E-46022, Valencia, Spain and the Dagger  Institut de Pharmacologie Moleculaire et Cellulaire, CNRS UPR411, 660 route des Lucioles, 06560, Valbonne, France

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We report the molecular cloning in Rattus norvegicus of a novel mammalian enzyme (RnPIP), which shows both 3'-phosphoadenosine 5'-phosphate (PAP) phosphatase and inositol-polyphosphate 1-phosphatase activities. This enzyme is the first PAP phosphatase characterized at the molecular level in mammals, and it represents the first member of a novel family of dual specificity enzymes. The phosphatase activity is strictly dependent on Mg2+, and it is inhibited by Ca2+ and Li+ ions. Lithium chloride inhibits the hydrolysis of both PAP and inositol-1,4-bisphosphate at submillimolar concentration; therefore, it is possible that the inhibition of the human homologue of RnPIP by lithium ions is related to the pharmacological action of lithium. We propose that the PAP phosphatase activity of RnPIP is crucial for the function of enzymes sensitive to inhibition by PAP, such as sulfotransferase and RNA processing enzymes. Finally, an unexpected connection between PAP and inositol-1,4-bisphosphate metabolism emerges from this work.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The sulfation reactions in mammals affect many different physiological processes, including deactivation and bioactivation of xenobiotics, inactivation of hormones and catecholamines, structure and function of macromolecules, and elimination of end products of catabolism (1). Sulfation involves the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS)1 to an acceptor molecule in a reaction that is catalyzed by a family of sulfotransferase enzymes (2). Usually, the obligate co-substrate PAPS donates its sulfuryl group to a functional hydroxyl group: PAPS + R-OH right-arrow PAP + R-OSO3-. The products are a sulfoconjugate (R-OSO3-) and 3'-phosphoadenosine 5'-phosphate (PAP). PAP is an inhibitory end product in any sulfation reaction because it acts as a competitive inhibitor with respect to PAPS (3). For instance, the M and P forms of human phenolsulfotransferases are potently inhibited by PAP, exhibiting a Ki value of approximately 0.1 µM (4).

In addition, a toxic effect of PAP on RNA processing enzymes (5' right-arrow 3' exoribonucleases) has been recently described in yeast (5). This effect might be attributed to the fact that PAP mimics the monomers of a polyribonucleotide chain and consequently, it might prevent the attack to the phosphodiester bond of RNA processing enzymes. These 5' right-arrow 3' exoribonucleases are highly conserved in evolution (5), therefore it is very likely that PAP accumulation in mammals has similar inhibitory effects on RNA processing, leading to aberrant changes in the pattern of gene expression. Consequently, a rapid removal of PAP is required both to maintain the activity of sulfotransferase enzymes and to prevent the accumulation of PAP to levels that could be inhibitory for RNA processing enzymes. Thus, it is reasonable to predict the existence in mammals of hydrolytic enzymes, such as PAP phosphatases, which could rapidly recycle PAP to AMP and inorganic phosphate. Indeed, a preliminary characterization of a 3',5'-bisphosphate nucleotidase purified from guinea pig liver has been reported (6), although this enzyme showed a very poor affinity for PAP (Km 3 mM). No clear role for this enzymatic activity nor molecular data of the corresponding gene have been reported.

In this work, we present for the first time the molecular cloning of a mammalian PAP phosphatase. The enzyme was cloned by functional complementation of a Saccharomyces cerevisiae hal2 mutant. Hal2 is a 3',5'-bisphosphate nucleotidase that specifically hydrolyzes the 3'-phosphate from PAP (7, 8), thereby preventing the accumulation of PAP. In yeast, PAP is generated as a side product of PAPS reductase, which is a key enzyme in the sulfate assimilation pathway that leads to the synthesis of methionine. PAP accumulation has deleterious effects on the cell because it inhibits PAPS reductase (9), and hence methionine biosynthesis, and RNA processing enzymes (5). The PAP phosphatase activity of Hal2 is crucial for the function of PAPS reductase, which is reflected in the fact that hal2 cells are auxotrophic for methionine (7, 10). We took advantage of this phenotype to clone the first mammalian PAP phosphatase by functional complementation of the auxotrophy for methionine of hal2 cells. Interestingly, the mammalian PAP phosphatase has a dual enzymatic activity, as it is also active as inositol-polyphosphate 1-phosphatase.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals-- All nonradioactive organic compounds were obtained from Sigma. Radioactive compounds were purchased from NEN Life Science Products. PAPS (Sigma) is supplied with 4 mol of lithium/mol of PAPS. Given the instability of this compound, removal of lithium is not recommended. [35S]PAPS (NEN Life Science Products) is obtained as the triethylammonium salt. Therefore, [35S]PAPS was the substrate employed to assay the activity of RnPIP against this compound.

Yeast Strain and Growth Media-- The Saccharomyces cerevisiae strain used in this study was JRM4 (MATa leu2-3, 112 ura3-251,328,372 hal2::LEU2), kindly provided by Dr. J. R. Murguia (Universidad Politécnica, Valencia, Spain). Complementation of the auxotrophy for methionine of the hal2 mutant was assayed in minimal synthetic glucose medium (SD), 2% glucose, 0.7% yeast nitrogen base without amino acids and 50 mM succinic acid adjusted to pH 5 with Tris. When indicated, the SD medium was supplemented with 100 µg/ml methionine to give SDM medium.

Cloning of RnPIP-- The yeast strain JRM4 was transformed with a Rattus norvegicus heart cDNA library constructed in the pFL61 vector (11), a yeast expression vector where expression of the rat cDNA is driven by the constitutive phosphoglycerate kinase (PGK) promoter. Transformants were first selected by uracil prototrophy in SDM. 105 primary transformants were obtained and pooled together. To select clones with the ability to complement the auxotrophy for methionine of the hal2 mutant, the primary transformants were spread on minimal medium lacking methionine. Four clones (pFL61-PIP) were obtained that complemented the auxotrophy for methionine of the hal2 mutant. The yeast shuttling plasmid was recovered by electroporation of Escherichia coli WM1100 cells. Partial sequencing and restriction analysis of the plasmids recovered from the E. coli transformants showed that all of them represented the same cDNA.

Expression of RnPIP in E. coli and Protein Purification-- The coding region of RnPIP was PCR-amplified from pFL61-PIP using Pwo DNA polymerase (Roche Molecular Biochemicals) and the following primers (XhoI site underlined): upstream, 5'-CCCCTCGAGATGGCTTCCAGC; downstream, 5'-CCCCTCGAGCCCCTTCAGGGAATGAG.

The PCR-amplified product was subcloned into the pT7-Blue vector (Novagen) to give pT7-PIP. The PIP open reading frame was released with XhoI and subcloned into the XhoI site of pGEX-KG (12), thus generating a fusion protein between glutathione S-transferase (GST) and PIP. The pGEX-KG-PIP construct was verified by sequencing with an ABI 377 automatic sequencer, and it was introduced into E. coli DH5alpha cells. The expression of the recombinant protein was induced with 0.1 mM isopropyl-1-thio-b-D-galactopyranoside for a period of 1 h at 30 °C, and the GST fusion protein was affinity purified on glutathione-Sepharose 4B (Amersham Pharmacia Biotech) as indicated by the suppliers. The pGEX-KG-PIP construct contains a thrombin cleavage site and a poly-glycine spacer between the GST and the RnPIP moieties (12). Thus, specific proteolysis of the fusion protein could be achieved by thrombin cleavage. The resulting RnPIP protein behaves identically to the GST fusion protein in the biochemical assays we have performed.

Enzyme Assay-- PAP phosphatase and inositol-polyphosphate 1phosphatase activities were assayed by one of the two following methods (8). Briefly, phosphatase activity was routinely assayed (assay 1) in a 100-µl mixture containing 50 mM Tris-HCl, pH 7.5, 1 mM magnesium chloride, and the indicated amount of GST fusion protein and substrate. After a 30-min incubation at 30 °C, the inorganic phosphate released was quantified by the malachite green method as described previously (13). Under these conditions, the enzyme activity was linear with protein quantity (up to 5 µg) and reaction time (up to 1 h). The concentration of either Ca2+ or Li+ that decreased the activity of the enzyme by 50% relative to a reaction without these cations (IC50) was estimated at a substrate concentration of 0.2 mM.

Assay 2 is described next, and it involved a HPLC analysis of the reaction products. The products were detected either by ultraviolet-absorption (8) or, in the case of radioactively labeled substrates, by coupling the HPLC device to a RadioFlow detector LB509 (EGG Berthold).

HPLC Analysis of the Hydrolysis of PAP, [35S]PAPS, and [3H]Inositol-1,4-bisphosphate-- The conditions for the HPLC analysis of the hydrolysis of PAP and PAPS have been described previously (8). To improve the resolution of the analysis of PAPS hydrolysis, the mobile phase was 3% methanol instead of 4%. Inositol-1,4-bisphosphate hydrolysis was assayed in a reaction mixture containing 0.2 M potassium Bicine (pH 8.0), 1 mM Mg2+, and 10 µM [3H]inositol-1,4-bisphosphate (10 Ci/mmol). At the indicated time, 10 µl of reaction mixture were injected into a 4.6 × 10-mm Guard Cartridge 10-µm SAX column linked to a 4.6 × 250-mm Partisil 10-µm SAX column (pS Phase Sep), equilibrated in Milli-Q water, and maintained at 22 °C with a flow rate of 1 ml/min. Inositol phosphates were eluted with a linear gradient of (NH4)H2PO4, pH 3.7, according to Jenkinson (14). [35S]PAPS, [35S]adenosine 5'-phosphosulfate, and [3H]inositol phosphates were detected with a RadioFlow detector LB509 (EGG Berthold) using Optiflow as scintillation mixture at a flow rate of 3 ml/min.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cloning of RnPIP-- To explore the presence in animals of PAP hydrolytic enzymes, a screening was conducted for mammalian genes that complement the auxotrophy for methionine of the yeast hal2 mutant. A rat cDNA library was constitutively expressed in hal2 cells, and as a result, a cDNA was identified that complemented the auxotrophy for methionine. Sequencing of this cDNA reveals a 927-base pair open reading frame that putatively encodes a protein of 308-amino acid residues with a molecular mass of 33.2 kDa (Fig. 1). The cDNA has 27 base pairs of 5'-untranslated sequence and 961 base pairs of 3'-untranslated region. The protein encoded by this gene, named RnPIP, complements the auxotrophy for methionine of hal2 cells to the same extent as Hal2, as demonstrated by the similar growth rates in methionine-free minimal medium of hal2 cells transformed with RnPIP or ScHAL2 (data not shown).


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 1.   The nucleotide sequence and the deduced amino acid sequence of the RnPIP cDNA. The amino acid sequence of the putative coding region is shown below the nucleotide sequence. Stop codons in frame with the open reading frame are indicated with an asterisk. An in frame TGA stop codon is found 12 nucleotides 5' to the first ATG translation initiation codon. The three conserved regions (17) involved in the coordination of phosphate and metal ions and nucleophilic water activation are indicated in boldface and are underlined. The nucleotide sequence of the RnPIP gene has been deposited at the GenBankTM/EBI data base under the accession number AJ000347.

Southern and Northern Blot Analyses-- A commercially available genomic DNA blot was used to analyze the presence of RnPIP in the rat genome as well as in other eukaryotic species (Fig. 2A). A major EcoRI hybridization band of approximately 4.0 kilobase pairs was detected in the rat genome. Other bands of lower intensity were also detected, suggesting that additional sequences related to RnPIP are present in the rat genome. Hybridization bands were also detected in the genome of mouse, dog, cow, rabbit, and chicken. Data base searches in the human nucleotide data base reveal the presence of human genes with high sequence similarity to RnPIP (see below). A rat multiple tissue Northern blot containing poly(A)+ RNA was used to examine the transcript level of the RnPIP gene in different tissues (Fig. 2B). The RnPIP mRNA was detected in all the tissues examined. The transcript level was especially high in heart, brain, and kidney. The size of the mRNA fits well with the length of the cDNA sequence reported above.


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 2.   Southern and Northern blot analyses of the RnPIP gene. A, a genomic DNA blot that contains DNA from seven eukaryotic species was supplied by CLONTECH. The blot contains approximately 4 µg of genomic DNA digested with EcoRI from each of the following species: rat, mouse, dog, cow, rabbit, chicken, and yeast. Hybridization with a radiolabeled full-length cDNA was performed under high stringency conditions (23). A 1 kilobase DNA ladder (Life Technologies, Inc.) was used as molecular size standards. B, a Northern blot containing approximately 2 µg of poly(A)+ RNA from eight different rat tissues was supplied by CLONTECH. The membrane was hybridized with a full-length cDNA probe. An RNA ladder (Life Technologies, Inc.) was used as molecular size standards. The size of the mRNA transcript is indicated in kilobases (kb).

Biochemical Characterization of the RnPIP Protein-- The RnPIP protein was expressed in E. coli as a GST fusion protein. Following induction with isopropyl-1-thio-b-D-galactopyranoside, the fusion protein was purified by affinity chromatography on glutathione-Sepharose resin. The phosphatase activity of the purified protein with respect to different substrates is summarized in Table I. PAP was the preferred substrate for RnPIP. The Km value for PAP hydrolysis was too low to be determined with the standard colorimetric assay (13) or even using the HPLC-based method where the products are detected by ultraviolet absorption (8). The detection limit of the HPLC analysis for PAP hydrolysis is approximately 2 µM, therefore the Km for PAP must be below 2 µM. PAPS was used as substrate with a 50% efficiency as compared with PAP. No appreciable activity was observed against AMP, 3'-AMP, fructose-1,6-bisphosphate, or pNPP. Interestingly, inositol-1,4-bisphosphate also served as a substrate for the enzyme, although with a 45% efficiency as compared with PAP. In addition, RnPIP hydrolyzed inositol-1,3,4-trisphosphate but not inositol-1,4,5-trisphosphate or inositol monophosphate. Therefore, besides the preferred PAP, RnPIP hydrolyzes the typical substrates of inositol-polyphosphate 1-phosphatase (15).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Substrate specificity of the RnPIP enzyme
The RnPIP protein was expressed in E. coli as a GST fusion protein and purified as described under "Experimental Procedures." The phosphatase activity was quantified by the malachite green method (13) as described under "Experimental Procedures." The activity obtained with different substrates (0.2 mM)a under conditions of maximal activity, pH 7.5 and 1 mM Mg2+, is expressed as the percent activity observed with 3'-PAP. The specific activity with 3'-PAP of GST-PIP was 0.8 µmol Pi × min-1 × milligram protein-1. The results are the average of two independent experiments, each performed in duplicate. Standard deviations were less than 5%.

To determine the position of the phosphate liberated from PAP and inositol-1,4-bisphosphate, we have analyzed by HPLC the reaction products of either PAP or inositol-1,4-bisphosphate hydrolysis (Fig. 3). RnPIP converts 3'-PAP to AMP by hydrolysis of the 3'-phosphate (Fig. 3A). The 2'-phosphate from 2'-PAP was also hydrolyzed by the enzyme, although with a lower efficiency. In this respect, RnPIP qualifies as a 3'(2'), 5'-bisphosphate nucleotidase. Inositol-1,4-bisphosphate was converted to inositol-4-phosphate (Fig. 3B), therefore RnPIP catalyzes the removal of the 1'-phosphate, as inositol-polyphosphate 1-phosphatase does.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 3.   Identification by HPLC analysis of the reaction products of either PAP or inositol-1,4-bisphosphate hydrolysis catalyzed by RnPIP. A, PAP hydrolysis. GST-PIP (1 µg) was incubated for 1 h at 30 °C in a buffer containing 0.2 M potassium Bicine (pH 8.0), 1 mM Mg2+, and 1 mM PAP as substrate (mixture of 3'-PAP and 2'-PAP). The conditions of the HPLC analysis have been previously described (8). 1, standards of AMP, 3'-(2')PAP, and 3'-AMP were analyzed to determine the retention time; 2, reaction mixture at time zero; 3, reaction mixture at 1 h. B, inositol-1,4-bisphosphate hydrolysis. GST-PIP (0.1 µg) was incubated for 10 min at 30 °C in a buffer containing 0.2 M potassium Bicine (pH 8.0), 1 mM Mg2+, and 10 µM [3H]inositol-1,4-bisphosphate (10 Ci/mmol). The conditions of the HPLC analysis are described in experimental procedures. 1, standards of [3H]inositol-1-phosphate (1), [3H]inositol-4-phosphate (4), and [3H]inositol-1,4-bisphosphate (1, 4) were analyzed to determine the retention time; 2, reaction mixture at time zero; 3, reaction mixture at 10 min.

Determination of the Km Values for PAPS and Inositol-1,4-bisphosphate Hydrolysis-- The sensitivity limit of the colorimetric assay for determination of inorganic phosphate prevents the determination of Km values in the low micromolar range. Fortunately, the above described HPLC analysis, together with the availability of [3H]inositol-1,4-bisphosphate and [35S]PAPS, made it possible to determine the Km values for these substrates (Table II). The apparent Km for inositol-1,4-bisphosphate was 0.2 µM ± 0.1. The Km for PAP could not be accurately determined, as radioactively labeled PAP is not available. [35S]PAPS is commercially available and RnPIP hydrolyzes the 3'-phosphate of PAPS with a 50% efficiency as compared with PAP, generating [35S]adenosine 5'-phosphosulfate (Table II). Therefore, although PAPS is not likely a physiological substrate for animal PAP phosphatases (16), we have also determined the Km value for PAPS. The apparent Km for [35S]PAPS was 1.2 µM ± 0.3. 

                              
View this table:
[in this window]
[in a new window]
 
Table II
Km and Vmax values for PAP, PAPS, and inositol-1,4-bisphosphate hydrolysis
Inositol-1,4-bisphosphate and PAPS hydrolysis were assayed in a reaction mixture containing 0.2 M potassium Bicine (pH 8.0), 1 mM Mg2+, and different concentrations of [3H]inositol-1,4-bisphosphate (10 Ci/mmol) or [35S]PAPS (1-3 Ci/mmol), respectively. The Km value for either inositol-1,4-bisphosphate or PAPS hydrolysis was determined by measuring reaction rates at substrate concentrations of 0.055, 0.166, 0.333, and 0.5 µM. The reaction products were analysed by HPLC and detected with a RadioFlow detector as described under "Experimental Procedures." The reaction product of either [3H]inositol-1,4-bisphosphate or [35S]PAPS hydrolysis is [3H]inositol-4-phosphate or [35S]adenosine 5'-phosphosulfate, respectively. The estimation of the Km value for PAP is described in the text. The Vmax values are equivalent to the data presented in Table I. The results are the average of two independent experiments, each performed in duplicate.

Cation Sensitivity of RnPIP-- Hal2 and inositol-polyphosphate 1-phosphatase belong to a family of magnesium-dependent, lithium-sensitive phosphatases (17). Accordingly, the phosphatase activity of RnPIP was strictly Mg2+-dependent, with an optimal concentration of 1 mM (data not shown). Ca2+ inhibited the phosphatase activity of RnPIP (Fig. 4A) (20 µM CaCl2 for 50% inhibition at 0.2 mM PAP), probably because of competition for Mg2+, as the inhibition was abolished by increasing the Mg2+ concentration (data not shown). RnPIP was not affected by high Na+ concentrations, whereas it was very sensitive to Li+ (0.8 mM LiCl for 50% inhibition at 0.2 mM PAP) (Fig. 4B). The effect of Li+ on this enzyme is unique among the group of monovalent cations (data not shown).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of Ca2+ and Li+ on the PAP phosphatase activity of RnPIP. A, inhibition by Ca2+. B, inhibition by Li+. Increasing amounts of either Ca2+ or Li+ were used in a standard phosphatase reaction with 2 µg of GST-PIP and 0.2 mM PAP as substrate. A similar inhibition was obtained when inositol-1,4-bisphosphate was used as substrate. The results are expressed as percent activity observed in the absence of cations and are the average of at least two independent experiments, each performed in duplicate. Standard deviations were less than 5%.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Biochemical characterization of the RnPIP protein shows that it is a dual enzyme that hydrolyzes both PAP and inositol-1,4-bisphosphate. The Vmax value for PAP hydrolysis was approximately 2-fold higher than for inositol-1,4-bisphosphate hydrolysis. Although the Km for PAP could not be accurately determined (<2 µM), we could determine the Km for the closely related substrate PAPS (1.2 µM) and for inositol-1,4-bisphosphate (0.2 µM), indicating a high affinity for these substrates. The enzyme is very sensitive to Li+ and, therefore, RnPIP is the fourth animal enzyme that is inhibited by Li+ ions in the therapeutic range, the other three being inositol monophosphate phosphatase (18), inositol-polyphosphate 1-phosphatase (15), and fructose-1,6-bisphosphatase (19). RnPIP is the first PAP phosphatase characterized at the molecular level in mammals, and a human homologue of RnPIP can be identified in the human data base of expressed sequence tags (ESTs) (Fig. 5). We predict that the human homologue of RnPIP will show a similar sensitivity to Li+ ions. Consequently, it might represent another target in lithium therapy, and the inhibition by lithium of the human enzyme could also contribute to the therapeutic or toxic effects of Li+ treatment.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 5.   Human ESTs share high similarity with RnPIP. A schematic diagram showing the amino acid alignment of RnPIP with human ESTs (HsEST) corresponding either to the N or C terminus of the protein is shown. The accession numbers for the EST1 and EST2 are H97426 and AA643182, respectively.

In addition to PAP phosphatase, RnPIP also qualifies as inositol-polyphosphate 1-phosphatase. A precedent for this sort of dual enzymatic activity is found in plants (20). The SAL1 enzyme of Arabidopsis thaliana exhibits both PAP phosphatase and inositol-polyphosphate 1-phosphatase activities. However, the hydrolysis of inositol-1,4-bisphosphate proceeds with a 34% efficiency as compared with PAP. Furthermore, the Km value for inositol-1,4-bisphosphate was much higher (90 µM) than the Km value for PAP (2 to 10 µM). In contrast, RnPIP hydrolyzes both PAP and inositol-1,4-bisphosphate with very high affinities. However, some features clearly distinguish the RnPIP enzyme from the canonical inositol-polyphosphate 1-phosphatase (15). First, RnPIP hydrolyzes both PAP and inositol-1,4-bisphosphate, whereas PAP hydrolysis by inositol-polyphosphate 1-phosphatase has not been reported. Second, bovine inositol-polyphosphate 1-phosphatase fails to complement the yeast hal2 mutant (data not shown). Finally, amino acid sequence comparison also reflects a clear difference between RnPIP and inositol-polyphosphate 1-phosphatase (Fig. 6). RnPIP is only 27% identical to bovine inositol-polyphosphate 1-phosphatase, whereas the mouse inositol-polyphosphate 1-phosphatase is 85% identical to bovine inositol-polyphosphate 1-phosphatase (Fig. 6). On the other hand, the sequence identity of RnPIP to non-animal PAP phosphatases is also low (25-30%) (Fig. 6). Instead, ESTs of proteins with unidentified function, which show high identity (60-90%) to RnPIP, are present in mouse, pig, fruit fly, and man (Fig. 6). For instance, comparison of human ESTs corresponding either to the N or the C terminus of RnPIP reveals 85-90% amino acid sequence identity to the respective part of RnPIP (Fig. 5). These data, taken together with the biochemical characterization of the protein, indicate that RnPIP is a novel mammalian enzyme, which probably represents the first member of an animal gene family of dual enzymes (Fig. 6).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Dendrogram representing the phylogenetic relationships of the novel family of dual specificity phosphatases, i.e. PAP-inositol-1,4-bisphosphate phosphatases (PIPases). The family of magnesium-dependent lithium-sensitive phosphatases comprises fructose-1,6-bisphosphatase (FBPases), inositol-polyphosphate 1-phosphatase (IPP1pases), inositol monophosphatase (IMPases), and PAP phosphatase (PAPases) enzymes (17). RnPIP is 20, 27, 30, 90, 31, 30, and 25% identical to AtFBP, BtIPP1, MmIPP, HsEST, AtSAL1, ScHal2, and ScImp1, respectively. The PILEUP program was employed to align the amino acid sequence of the following proteins and ESTs: AtFBP (A. thaliana, Swiss-Prot P25851), BnFBP (Brassica napus, Swiss-Prot Q07204), BtIPP1 (Bos taurus, Swiss-Prot P21327), HsIPP1 (Homo sapiens, Swiss-Prot P49441), MmIPP (Mus musculus, Swiss-Prot P49442), RnPIP (R. norvegicus, EBI AJ000347), MmEST (M. musculus, GenBankTM AA008240), HsEST (H. sapiens, GenBankTM H97426), SsEST (Sus scrofa, EBI Z84066), DmEST (Drosophila melanogaster, GenBankTM AA990707), AtSAL1 (A. thaliana, GenBankTM U40433), AtSAL2 (A. thaliana, EBI Z83312), OsRHL (Oryza sativa, GenBankTM U33283), AtAHL(A. thaliana, GenBankTM U55205), ScHal2 (S. cerevisiae, Swiss-Prot P32179), and EcCysQ (E. coli, Swiss-Prot P26264), ScImp1 (S. cerevisiae, PIR S70117), ScImp2 (S. cerevisiae, Swiss-Prot P38710), AnQutG (Aspergillus nidulans, Swiss-Prot P25416), HsIMP(H. sapiens, EBI S38980), BtIMP (B. taurus, EBI J05394), XlIMP (Xenopus laevis, EBI X65513), LeIMP1 (Lycopersicon esculentum, Swiss-Prot P54926), and EcSuhB (E. coli, Swiss-Prot P22783).

In summary, we propose that the PAP phosphatase activity of RnPIP, by preventing accumulation of PAP, is necessary to maintain active sulfotransferase (6, 21) and RNA processing enzymes (5). RNA processing is crucial in cell metabolism. The importance of sulfation in animals is illustrated by the phenotype of brachymorphic mice, which have abnormal hepatic detoxification, bleeding times, and postnatal growth (22). This phenotype is because of a missense mutation in SK2 (sulfurylase kinase 2) (22), a member of the gene family encoding the bifunctional enzymes that synthesize the universal sulfate donor, PAPS. In addition, the inositol-polyphosphate 1-phosphatase activity of RnPIP could play a role in the phosphoinositide-signaling pathway. Finally, the unexpected connection between PAP and inositol-1,4-bisphosphate metabolism remains to be investigated.

    FOOTNOTES

* This project was supported by Grants AIR3-CT94-1508 and BIO4-CT96-0775 of the European Union (Brussels).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AJ000347.

§ To whom correspondence should be addressed. Tel.: 34 96 3877860; Fax: 34 96 3877859; E-mail: prodriguez{at}ibmcp.upv.es.

    ABBREVIATIONS

The abbreviations used are: PAPS, 3'-phosphoadenosine 5'-phosphosulfate; PAP, 3'-phosphoadenosine 5'-phosphate; GST, glutathione S-transferase; HPLC, high performance liquid chromatography; Bicine, N,N-bis(2-hydroxyethyl)glycine; pNPP, p-nitrophenyl phosphate; EST, expressed sequence tag.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Klaassen, C. D., and Boles, J. W. (1997) FASEB J. 11, 404-418[Abstract/Free Full Text]
  2. Weinshilboum, R. M., Otterness, D. M., Aksoy, I. A., Wood, T. C., Her, C., and Raftogianis, R. B. (1997) FASEB J. 11, 3-14[Abstract/Free Full Text]
  3. Roth, J. A., Rivett, A. J., and Renskers, K. J. (1982) in Sulfate Metabolism and Sulfate Conjugation (Mulder, G. J., Caldwell, J., Van Kempen, G. M. J., and Vonk, R. J., eds), pp. 107-114, Taylor and Francis, London
  4. Rens-Domiano, S. S., and Roth, J. A. (1987) J. Neurochem. 48, 1411-1415[Medline] [Order article via Infotrieve]
  5. Dichtl, B., Stevens, A., and Tollervey, D. (1997) EMBO J. 16, 7184-7195[Abstract/Free Full Text]
  6. Ramaswamy, S. G., and Jakoby, W. B. (1987) J. Biol. Chem. 262, 10044-10047[Abstract/Free Full Text]
  7. Glaser, H. U., Thomas, D., Gaxiola, R., Montrichard, F., Surdin, K., Y., and Serrano, R. (1993) EMBO J. 12, 3105-3110[Abstract]
  8. Murguia, J. R., Belles, J. M., and Serrano, R. (1995) Science 267, 232-234[Medline] [Order article via Infotrieve]
  9. Schwenn, J. D., Krone, F. A., and Husmann, K. (1988) Arch. Microbiol. 150, 313-319[Medline] [Order article via Infotrieve]
  10. Thomas, D., Barbey, R., Henry, D., and Surdin-Kerjan, Y. (1992) J. Gen. Microbiol. 138, 2021-2028[Medline] [Order article via Infotrieve]
  11. Lesage, F., Hugnot, J. P., Amri, E. Z., Grimaldi, P., Barhanin, J., and Lazdunski, M. (1994) Nucleic Acids Res. 22, 3685-3688[Abstract]
  12. Guan, K. L., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[Medline] [Order article via Infotrieve]
  13. Baykov, A. A., Evtushenko, O. A., and Avaeva, S. M. (1988) Anal. Biochem. 171, 266-270[Medline] [Order article via Infotrieve]
  14. Jenkinson, S. (1995) Methods Mol. Biol. 41, 151-165[Medline] [Order article via Infotrieve]
  15. Majerus, P. W. (1992) Annu. Rev. Biochem. 61, 225-250[CrossRef][Medline] [Order article via Infotrieve]
  16. Murguia, J. R., Belles, J. M., and Serrano, R. (1996) J. Biol. Chem. 271, 29029-29033[Abstract/Free Full Text]
  17. York, J. D., Ponder, J. W., and Majerus, P. W. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 5149-5153[Abstract]
  18. Hallcher, L. M., and Sherman, W. R. (1980) J. Biol. Chem. 255, 10896-10901[Abstract/Free Full Text]
  19. Marcus, F., and Hosey, M. M. (1980) J. Biol. Chem. 255, 2481-2486[Free Full Text]
  20. Quintero, F. J., Garciadeblas, B., and Rodriguez-Navarro, A. (1996) Plant Cell 8, 529-537[Abstract/Free Full Text]
  21. Brunngraber, E. G. (1958) J. Biol. Chem. 233, 472-477[Free Full Text]
  22. Kurima, K., Warman, M. L., Krishnan, S., Domowicz, M., Krueger, R. C., Jr., Deyrup, A., and Schwartz, N. B. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8681-8685[Abstract/Free Full Text]
  23. Church, G. M., and Gilbert, W. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 1991-1995[Abstract]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.